Plasma samples from a total of 376 subjects (see above for details and ethical approvals), from two independent cohorts, were analyzed via DI-FT-ICR MS (
24 (
link),
41 (
link)). Before analyses, the metabolites (from 50 μl of blood plasma) were extracted by C18 solid-phase extraction (SPE) technology, using
Omix C18 100 μl tips (Varian) and following the protocol described by Forcisi
et al. (
24 (
link)). The extracts, diluted in methanol by a factor of 50, were analyzed in positive ESI mode via DI-FT-ICR MS, using a Bruker SolariX instrument equipped with a
12-T magnet (Bruker Daltonik GmbH, Bremen, Germany). The instrument was externally calibrated by injecting a solution of arginine (10 μg/ml) and observing corresponding peaks with
m/z values equal to 175.11895 [M+H]
+, 349.23062 [2M+H]
+, 523.34230 [3M+H]
+, and 697.45397 [4M+H]
+. In the experiment, the flow rate of infusion was set to 120 μl/hour. Four hundred scans, each corresponding to 4 MWs in the interval from 147.4 to 1000.0
m/z, were acquired and averaged. The time of accumulation ion was set to 0.7 s, and the time of flight to the detector was set to 1 ms. The voltages of capillary and spray shields were set to 3800 and −500 V, respectively. The flow rate of nebulizer gas was kept at 2.2 bar, and the drying gas flow rate was set to 4 liters/min (at a temperature of 180°C).
Laber S., Forcisi S., Bentley L., Petzold J., Moritz F., Smirnov K.S., Al Sadat L., Williamson I., Strobel S., Agnew T., Sengupta S., Nicol T., Grallert H., Heier M., Honecker J., Mianne J., Teboul L., Dumbell R., Long H., Simon M., Lindgren C., Bickmore W.A., Hauner H., Schmitt-Kopplin P., Claussnitzer M, & Cox R.D. (2021). Linking the FTO obesity rs1421085 variant circuitry to cellular, metabolic, and organismal phenotypes in vivo. Science Advances, 7(30), eabg0108.